NecroX as a novel class of mitochondrial reactive oxygen species and ONOO⁻ scavenger

Area of Science:

• Biochemistry
• Cell Biology
• Pharmacology

Background:

• Mitochondrial reactive oxygen species (ROS) and reactive nitrogen species (RNS) contribute to oxidative stress and nonapoptotic cell death.
• Oxidative stress is implicated in various human disorders characterized by cell death pathways distinct from apoptosis, autophagy, and necroptosis.

Purpose of the Study:

• To investigate the cytoprotective effects of the NecroX series against various cellular stresses.
• To determine if NecroX compounds can inhibit nonapoptotic cell death mechanisms.

Main Methods:

• Exposure of cells to pro-oxidants (tertiarybutylhydroperoxide), doxorubicin, carbon tetrachloride (CCl₄), and hypoxic conditions.
• Assessment of cell death morphology and caspase-independent pathways.
• Measurement of mitochondrial ROS and peroxynitrite (ONOO⁻) scavenging activity.
• In vivo studies using C57BL/6 mice with streptozotocin-induced diabetes and CCl₄-induced hepatotoxicity.

Main Results:

• NecroX series compounds inhibited caspase-independent cell death with necrotic morphology.
• These molecules demonstrated significant scavenging activity against mitochondrial ROS and ONOO⁻.
• Oral administration of NecroX compounds attenuated pancreatic islet β-cell destruction and CCl₄-induced hepatotoxicity in mice.

Conclusions:

• The NecroX series effectively blocks nonapoptotic cell death induced by mitochondrial oxidative stress.
• NecroX compounds possess potent ROS and ONOO⁻ scavenging capabilities.
• These findings suggest the NecroX series holds potential as therapeutic agents for mitochondria-related diseases involving necrotic injury.